COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.
Cross AH, Delgado S, Habek M, Davydovskaya M, Ward BJ, Cree BAC, Totolyan N, Pingili R, Mancione L, Hu X, Sullivan R, Su W, Zielman R, Gupta AD, Montalban X, Winthrop K.
Cross AH, et al. Among authors: ward bj.
Neurol Ther. 2022 Jun;11(2):741-758. doi: 10.1007/s40120-022-00341-z. Epub 2022 Mar 13.
Neurol Ther. 2022.
PMID: 35284994
Free PMC article.